The effects of prostaglandin E 2 (PGE 2 ) on the parameters for proliferation and differentiation were studied in calvarial osteoblast-like cells isolated from rats of various ages. In cells not treated with PGE 2 , it was found that mineralized bone nodule (BN) formation, alkaline phosphatase (ALP)
Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts
✍ Scribed by Hiroyuki Kaneki; Ikuko Takasugi; Masaki Fujieda; Michiaki Kiriu; Shigeki Mizuochi; Hayao Ide
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 259 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
The effects of prostaglandin E 2 (PGE 2 ) on the proliferation and differentiation of osteoblastic cells were studied in osteoblast-like cells isolated from adult rat calvaria. Treatment of the cells with PGE 2 within the concentration range 10 Ϫ8 -10 Ϫ5 M resulted in a dose-dependent increase in alkaline phosphatase (ALP) activity, [ 3 H]proline incorporation into collagenase-digestible protein, and mineralized bone nodule (BN) formation, as well as a dose-dependent decrease in [ 3 H]thymidine incorporation into the cells. PGE 2 also caused a dose-dependent increase in the intracellular cyclic adenosine monophosphate (cAMP) content, with a maximal effective concentration of 10 Ϫ5 M; this effect of PGE 2 was mimicked by forskolin, an adenylate cyclase activator. The treatment of adult calvarial cells with forskolin decreased BN formation, ALP activity, and collagen synthesis. These results suggested that cAMP does not have a stimulatory, but rather a suppressive, effect on the differentiation of adult rat calvarial cells. A time-course study of cAMP accumulation showed that both PGE 2 -and forskolin-induced cAMP reached a maximum at 5 min after the treatment, but the former rapidly returned to the basal level by 40 min, while the latter declined slowly and was still at 70% of the maximal level at 60 min, suggesting that PGE 2 activates phosphodiesterase as well as adenylate cyclase. The presence of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), a calmodulin antagonist, reduced the rate of degradation of cAMP formed after PGE 2 treatment, suggesting the involvement of calmodulin in the activation of phosphodiesterase. However, PGE 2 also caused the production of inositol 1,4,5-triphosphate (IP 3 ) and an elevation of the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), both of which peaked at 15 s and returned to the basal level within 1 min. Submaximal responses of the IP 3 production and the [Ca 2ϩ ] i elevation to PGE 2 were obtained at 10 Ϫ5 M. W-7 decreased both basal and PGE 2 -induced ALP activity, collagen synthesis and BN formation, indicating the involvement of Ca 2ϩ /calmodulindependent protein kinase in the PGE 2 -induced differentiation of calvarial cells. From these results, we concluded that PGE 2 inhibits the proliferation and stimulates the differentiation of calvarial osteoblasts by elevating the [Ca 2ϩ ] i through the activation of a phosphoinositide turnover, but not via an activation of adenylate cyclase. We also found that BN formation varies, depending on the time of PGE 2 addition, suggesting that responsiveness of the cells to PGE 2 may change during the culture period.
📜 SIMILAR VOLUMES